Typhlitis as a complication of alemtuzumab therapy
Alemtuzumab is a humanized monoclonal antibody directed against lymphocytes through the CD-52 receptor, an antigen being found on > 95% of peripheral blood lymphocytes and monocytes, and to a smaller extent on granulocytes.1–7 It is an effective immunotherapeutic agent in patients with malignanci...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2007-05-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/4457 |